Oramed Pharmaceuticals

ORMP

Börsenwert 169 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Bank of New York Mellon New York	381.217 $	+315.498 $	+79.255	Neu
27	27 UBS Group Zurich, Switzerland	325.498 $	+222.941 $	+56.004	+480 %
28	28 American Century Companies Kansas City, Missouri	287.518 $	+109.345 $	+27.468	+85 %
29	29 XTX Topco George Town, Cayman Islands	240.130 $	+108.417 $	+27.235	+120 %
30	30 Nuveen Charlotte, North Carolina	223.203 $	+184.725 $	+46.404	Neu
31	31 Morgan Stanley New York	208.547 $	+116.657 $	+29.305	+209 %
32	32 Citadel Advisors Miami, Florida	199.927 $	-227.160 $	-57.064	-58 %
33	33 Deutsche Bank Frankfurt Am Main Ge, Germany	159.682 $	+132.155 $	+33.198	Neu
34	34 Prelude Capital Management New York	157.350 $	-10.350 $	-2.600	-7 %
35	35 Bailard Foster City, California	156.219 $	–	–	–
36	36 RhumbLine Advisers Boston, Massachusetts	147.281 $	+121.896 $	+30.621	Neu
37	37 Algert Global San Francisco, California	139.288 $	+38.773 $	+9.740	+51 %
38	38 T. Rowe Price Associates Baltimore, Maryland	135.000 $	+111.100 $	+27.909	Neu
39	39 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	121.246 $	-99.520 $	-25.000	-50 %
40	40 Invesco Atlanta, Georgia	119.052 $	+98.529 $	+24.751	Neu
41	41 Susquehanna International Group Bala Cynwyd, Pennsylvania	107.263 $	-453.485 $	-113.918	-84 %
42	42 Millennium Management New York	105.151 $	+23.260 $	+5.843	+36 %
43	43 PNC Financial Services Group Pittsburgh, Pennsylvania	101.972 $	–	–	–
44	RFW 44 Redwood Family Wealth Addison, Texas	99.783 $	-5.255 $	-1.320	-6 %
45	SCM 45 Sage Capital Management Stockton, New Jersey	86.474 $	–	–	–
46	46 Citigroup New York	76.037 $	+27.145 $	+6.819	+76 %
47	47 Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong	75.378 $	+62.383 $	+15.671	Neu
48	48 Vanguard Fiduciary Trust Malvern, Pennsylvania	67.811 $	+56.121 $	+14.098	Neu
49	49 JP Morgan Chase New York	65.693 $	+30.927 $	+7.769	+122 %
50	50 Y-Intercept (HK) Hong Kong	61.650 $	+51.022 $	+12.817	Neu

Oramed Pharmaceuticals ORMP Börsenwert 169 Mio. $

Oramed Pharmaceuticals

ORMP

Börsenwert 169 Mio. $